Overview
FOXP1 syndrome is a rare genetic condition caused by changes (mutations) in the FOXP1 gene. This gene plays an important role in brain development, and when it does not work properly, it can lead to a range of developmental and neurological challenges. The condition is also sometimes called FOXP1-related intellectual disability or mental retardation, autosomal dominant 32 (MRD32). Children with FOXP1 syndrome typically show delays in speech and language development, which is often one of the earliest and most noticeable features. Most individuals have mild to moderate intellectual disability, and many experience difficulties with motor skills such as walking and coordination. Behavioral features are common and can include autism spectrum traits, anxiety, and attention difficulties. Some children also have heart defects, vision problems, or distinctive facial features. There is currently no cure for FOXP1 syndrome. Treatment focuses on managing symptoms and supporting development through speech therapy, occupational therapy, physical therapy, and behavioral interventions. Early intervention services can make a meaningful difference in a child's progress. Some individuals may need additional support for heart problems or other medical issues. Research into this condition is ongoing, and the medical community continues to learn more about how best to support affected individuals and their families.
Key symptoms:
Delayed speech and language developmentIntellectual disability (usually mild to moderate)Delayed motor milestones like sitting and walkingAutism spectrum featuresAnxiety and mood difficultiesAttention and hyperactivity problemsLow muscle tone (feeling floppy)Heart defects (present in some individuals)Distinctive facial featuresVision problems such as strabismus (crossed eyes)Feeding difficulties in infancyCoordination and balance problemsKidney or urinary tract abnormalities (in some cases)Sleep difficulties
Clinical phenotype terms (50)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for FOXP1 Syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for FOXP1 Syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to FOXP1 Syndrome.
Community
No community posts yet. Be the first to share your experience with FOXP1 Syndrome.
Start the conversation →Latest news about FOXP1 Syndrome
No recent news articles for FOXP1 Syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic change was found in my child's FOXP1 gene, and what does it mean?,Should my child have a heart evaluation or other organ screening?,What therapies should we start right away, and how often should they occur?,Are there any clinical trials or research studies for FOXP1 syndrome that we could participate in?,What should we expect in terms of speech and language development over time?,How should we plan for my child's educational needs, and what school supports are available?,Is there a risk that future children could also have FOXP1 syndrome?
Common questions about FOXP1 Syndrome
What is FOXP1 Syndrome?
FOXP1 syndrome is a rare genetic condition caused by changes (mutations) in the FOXP1 gene. This gene plays an important role in brain development, and when it does not work properly, it can lead to a range of developmental and neurological challenges. The condition is also sometimes called FOXP1-related intellectual disability or mental retardation, autosomal dominant 32 (MRD32). Children with FOXP1 syndrome typically show delays in speech and language development, which is often one of the earliest and most noticeable features. Most individuals have mild to moderate intellectual disability,
How is FOXP1 Syndrome inherited?
FOXP1 Syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does FOXP1 Syndrome typically begin?
Typical onset of FOXP1 Syndrome is infantile. Age of onset can vary across affected individuals.
Which specialists treat FOXP1 Syndrome?
23 specialists and care centers treating FOXP1 Syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.